US Patent Issued to MEDICINAL BIOCONVERGENCE RESEARCH CENTER on Sept. 13 for "Method for screening anticancer agent inhibiting binding of AIMP2-DX2 and HSP70" (South Korean Inventors)

Press/Media: Press / Media

Period2022 Sep 13

Media coverage

1

Media coverage

  • TitleUS Patent Issued to MEDICINAL BIOCONVERGENCE RESEARCH CENTER on Sept. 13 for "Method for screening anticancer agent inhibiting binding of AIMP2-DX2 and HSP70" (South Korean Inventors)
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date22/9/13
    PersonsSunghoon Kim